entity

ALS/FTD

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ALS/FTD: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

25Connections

11Hypotheses

9Analyses

0Outgoing

25Incoming

0Experiments

13Debates

No AI portrait yet

Wiki Pages (20)

Knowledge base pages for this entity

Validated Hypothesis: Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 Proteinopathy Neuroinflammation in ALS/FTD

hypothesis · 5607 words

→

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (25)

Source	Relation	Type	Str
polyunsaturated fatty acids (PUFAs)	protects_against	compound	1.00
C9ORF72	associated_with	gene	0.95
FBL	contributes_to	gene	0.95
TARDBP MUTATIONS	causes	gene	0.90
TDP-43 INCLUSIONS	associated_with	phenotype	0.90
TBK1 haploinsufficiency	risk_factor_for	process	0.90
TDP-43	causes	protein	0.90
G4C2 Repeat Expansion	causes	biomarker	0.90
TDP-43 Dysfunction	contributes_to	mechanism	0.90
TDP-43	associated_with	protein	0.90
C9orf72	risk_factor_for	gene	0.90
FUS	associated_with	protein	0.90
VCP	risk_factor_for	gene	0.90
TBK1	risk_factor_for	gene	0.90
C9orf72 hexanucleotide repeat	risk_factor_for	gene	0.90
pathological stress granules	associated_with	phenotype	0.90
RNA Condensates	contributes_to	process	0.85
P53	risk_factor_for	gene	0.85
Circadian Rhythm Disruption	associated_with	phenotype	0.80
FBL	contributes_to	protein	0.80
FBL	implicated_in	protein	0.75
liquid-to-solid transition	risk_factor_for	mechanism	0.70
stress granule	risk_factor_for	process	0.70
TBK1	increases_risk	gene	0.70
C9ORF72	causes	gene	0.70

Targeting Hypotheses (11)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Microglial AIM2 Inflammasome as the Primary Driver of TDP-43	0.824	neurodegeneration	What are the mechanisms by which gut mic
ASO-mediated reduction of toxic C9orf72 dipeptide repeat pro	0.760	neurodegeneration	Test
C9orf72 ASO Treatment Reverses TDP-43 Pathology in ALS/FTD	0.720	neurodegeneration	Test Hypothesis Fixtures
C9orf72 repeat RNA and dipeptide-repeat toxicity in ALS/FTD	0.700	neurodegeneration	Test
TDP-43 phase-separation and nuclear-function failure in ALS/	0.690	neurodegeneration	Test

ATXN2 Antisense Oligonucleotides Reduce Dipeptide Repeat Pro	0.630	neurodegeneration	Test
TDP-43 LLPS and proteostasis dysregulation in ALS/FTD	0.600	neurodegeneration	Test
C9orf72 Nucleocytoplasmic Transport Rescue for ALS/FTD	0.597	neurodegeneration	Test
Small-Molecule Modulation of TDP-43 Liquid-Liquid Phase Sepa	0.565	neurodegeneration	Test
Rational design of small molecules targeting TDP-43 liquid-t	0.510	neurodegeneration	Test
Astrocyte GAT-3 dysfunction and inhibitory-network disruptio	0.490	neurodegeneration	Test

Mentioning Analyses (9)

Scientific analyses that reference this entity

Cross-disease neurodegeneration mechanism synthesis

neurodegeneration | 2026-04-28 | 17 hypotheses Top: 0.828

What are the mechanisms by which microglial senescence contributes to ALS pathol

neurodegeneration | 2026-04-26 | 12 hypotheses Top: 0.878

How does FUS loss-of-function in TAZ regulation contribute to ALS/FTD pathogenes

neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.720

How can CRISPR systems achieve persistent therapeutic effects while avoiding chr

gene therapy | 2026-04-11 | 0 hypotheses

What determines the spatial organization of autophagy receptors at stress granul

neurodegeneration | 2026-04-08 | 5 hypotheses Top: 0.633

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (5)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861]	["Han X", "Sun S", "Sun Y", "Song Q", "Z	Autophagy	2020	1
Inhibition of autophagy in microglia and macrophages exacerbates innate immune r [PMID:36652438]	Hegdekar N, Sarkar C, Bustos S, Ritzel R	Autophagy	2023	0
Inflammasome assembly in neurodegenerative diseases. [PMID:37633753]	Singh J, Habean ML, Panicker N	Trends in neurosciences	2023	0
NLRP3/caspase-1/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pat [PMID:34877938]	Li S, Sun Y, Song M, Song Y, Fang Y, Zha	JCI insight	2021	0
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodeg [PMID:30381407]	Gordon R, Albornoz EA, Christie DC, Lang	Science translational medicine	2018	0

Debates (13)

Multi-agent debates referencing this entity

Which AD, PD, ALS, and FTD mechanisms recur across disease boundaries and yield

closed · Rounds: 4 · Score: 0.72 · 2026-04-28

Debate: Liquid-to-Solid Transition Pathology Reveals Granule Weak Points

closed · Rounds: 4 · Score: 0.58 · 2026-04-27

Debate: TBK1 Loss Locks Microglia in an Aged/Senescent Transcriptional State, Fu

closed · Rounds: 4 · Score: 0.33 · 2026-04-27

Investigate how microglial senescence drives ALS progression through inflammatio

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

What are the mechanisms by which microglial senescence contributes to ALS pathol

closed · Rounds: 6 · Score: 0.75 · 2026-04-26

The study shows TRIM21 and autophagy receptors can eliminate both physiological

closed · Rounds: 4 · Score: 0.75 · 2026-04-22

The study shows that G3BP1 ubiquitination inhibits LLPS in vitro, but the molecu

closed · Rounds: 4 · Score: 0.79 · 2026-04-21

While the study identifies G3BP1 as a central node triggering phase separation,

closed · Rounds: 4 · Score: 0.76 · 2026-04-21

SQSTM1 and CALCOCO2 specifically localize to SG periphery rather than throughout

closed · Rounds: 4 · Score: 0.69 · 2026-04-21

The debate highlighted that long-term CRISPR expression triggers immune response

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

Related Research

Hypotheses and analyses mentioning ALS/FTD in their description or question text

ATXN2 Antisense Oligonucleotides Reduce Dipeptide Repeat Proteins in C9orf72-ALS

Score: 0.630 · neurodegeneration · 2026-05-10

ASO-mediated knockdown of ATXN2 reduces repeat-associated non-AUG translation of toxic dipeptide repeat proteins from C9

TDP-43 LLPS and proteostasis dysregulation in ALS/FTD

Score: 0.600 · neurodegeneration · 2026-04-29

TDP-43 stress-granule entry and liquid-liquid phase separation may transition from reversible condensates into pathologi

C9orf72 Nucleocytoplasmic Transport Rescue for ALS/FTD

Score: 0.597 · neurodegeneration · 2026-05-06

C9orf72 intronic GGGGCC repeats produce dipeptide repeat proteins and RNA foci that sequester nuclear import factors (TN

Small-Molecule Modulation of TDP-43 Liquid-Liquid Phase Separation for ALS/FTD

Score: 0.565 · neurodegeneration · 2026-05-10

High-throughput screening for compounds that restore proper TDP-43 granule dynamics by preventing pathological liquid-to

Rational design of small molecules targeting TDP-43 liquid-to-solid phase transi

Score: 0.510 · neurodegeneration · 2026-05-01

TDP-43 undergoes pathological liquid-liquid phase separation in ALS/FTD, and small molecules that restore liquid-like pr

Astrocyte GAT-3 dysfunction and inhibitory-network disruption in ALS/FTD

Score: 0.490 · neurodegeneration · 2026-04-30

Astrocytic GABA transporter dysfunction may contribute to extracellular GABA changes, chloride-gradient disruption, and

ALS/FTD

Understanding Entity Pages

Wiki Pages (20)

Validated Hypothesis: Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 Proteinopathy Neuroinflammation in ALS/FTD

Epigenetic Dysregulation Comparison -- AD/PD/ALS/FTD/HD

Lipid Metabolism Dysfunction Comparison — AD/PD/ALS/FTD/HD

Autophagy-Lysosomal Impairment Comparison — AD/PD/ALS/FTD/HD

Autophagy Failure Comparison -- AD/PD/ALS/FTD/HD

C9orf72→RNA/Dipeptide Repeat Pathology→ALS/FTD — Causal Chain

Neuroinflammation Comparison — AD/PD/ALS/FTD/HD

FUS Gene-Mechanism-Therapy Causal Chain — ALS/FTD

Neurovascular Coupling Disease Comparison — AD/PD/ALS/FTD/HD

VCP→TDP-43→ALS/FTD Causal Chain

OPTN (Optineurin) Mitophagy Dysfunction — ALS/FTD/PD Causal Chain

PTPσ (PTPRS) in C9ORF72-ALS/FTD - PI3P Regulation Mechanism

Myelin Pathology Disease Comparison — AD/PD/ALS/FTD/HD

PGC-1α Mitochondrial Biogenesis Comparison — AD/PD/ALS/FTD/HD

Antisense Oligonucleotide Therapy for C9orf72 ALS/FTD

Ferroptosis Disease Comparison — AD/PD/ALS/FTD/HD

Motor Neurons in C9orf72-Linked ALS/FTD

Cytoskeleton Dysfunction Comparison -- AD/PD/ALS/FTD/HD

Stress Granule Homeostasis in ALS/FTD

Dipeptide Repeat Proteins (DPRs) in C9orf72-ALS/FTD

Outgoing (0)

Incoming (25)

Targeting Hypotheses (11)

Mentioning Analyses (9)

Cross-disease neurodegeneration mechanism synthesis

What are the mechanisms by which microglial senescence contributes to ALS pathol

How does FUS loss-of-function in TAZ regulation contribute to ALS/FTD pathogenes

How can CRISPR systems achieve persistent therapeutic effects while avoiding chr

What determines the spatial organization of autophagy receptors at stress granul

What determines the specificity of RNA-protein interactions that drive distinct

How does TRIM21-mediated K63 ubiquitination of G3BP1 mechanistically inhibit liq

How do pathological stress granules in neurodegeneration escape TRIM21/autophagy

TDP-43 phase separation therapeutics for ALS-FTD

Experiments (0)

Related Papers (5)

Debates (13)

Which AD, PD, ALS, and FTD mechanisms recur across disease boundaries and yield

Debate: Liquid-to-Solid Transition Pathology Reveals Granule Weak Points

Debate: TBK1 Loss Locks Microglia in an Aged/Senescent Transcriptional State, Fu

Investigate how microglial senescence drives ALS progression through inflammatio

What are the mechanisms by which microglial senescence contributes to ALS pathol

The study shows TRIM21 and autophagy receptors can eliminate both physiological

The study shows that G3BP1 ubiquitination inhibits LLPS in vitro, but the molecu

While the study identifies G3BP1 as a central node triggering phase separation,

SQSTM1 and CALCOCO2 specifically localize to SG periphery rather than throughout

The debate highlighted that long-term CRISPR expression triggers immune response

Related Research

ATXN2 Antisense Oligonucleotides Reduce Dipeptide Repeat Proteins in C9orf72-ALS

TDP-43 LLPS and proteostasis dysregulation in ALS/FTD

C9orf72 Nucleocytoplasmic Transport Rescue for ALS/FTD

Small-Molecule Modulation of TDP-43 Liquid-Liquid Phase Separation for ALS/FTD

Rational design of small molecules targeting TDP-43 liquid-to-solid phase transi

Astrocyte GAT-3 dysfunction and inhibitory-network disruption in ALS/FTD